Israeli researchers have developed a method to measure PTEN gene activity in the brain, aiding research on cell growth and diseases like cancer, autism, and epilepsy. Published in Nature Methods, this tool enhances understanding of PTEN-related disorders and could lead to early disease detection and personalized treatments by tracking gene activity in various biological settings.